CO6801771A2 - Oral composition comprising sodium divalproexy process to prepare the same - Google Patents

Oral composition comprising sodium divalproexy process to prepare the same

Info

Publication number
CO6801771A2
CO6801771A2 CO13264524A CO13264524A CO6801771A2 CO 6801771 A2 CO6801771 A2 CO 6801771A2 CO 13264524 A CO13264524 A CO 13264524A CO 13264524 A CO13264524 A CO 13264524A CO 6801771 A2 CO6801771 A2 CO 6801771A2
Authority
CO
Colombia
Prior art keywords
divalproexy
prepare
sodium
same
oral composition
Prior art date
Application number
CO13264524A
Other languages
Spanish (es)
Inventor
Dipak Sahana
Prasad Patil
Ganesh Narayan Phadtare
Manish Grover
Shripad Jathar
Original Assignee
Abbott Healthcare Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46939730&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6801771(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Healthcare Private Ltd filed Critical Abbott Healthcare Private Ltd
Publication of CO6801771A2 publication Critical patent/CO6801771A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO13264524A 2011-05-02 2013-11-08 Oral composition comprising sodium divalproexy process to prepare the same CO6801771A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1365MU2011 2011-05-02

Publications (1)

Publication Number Publication Date
CO6801771A2 true CO6801771A2 (en) 2013-11-29

Family

ID=46939730

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13264524A CO6801771A2 (en) 2011-05-02 2013-11-08 Oral composition comprising sodium divalproexy process to prepare the same

Country Status (6)

Country Link
BR (1) BR112013027685A2 (en)
CL (1) CL2013003137A1 (en)
CO (1) CO6801771A2 (en)
EC (1) ECSP13013043A (en)
MX (1) MX2013012827A (en)
WO (1) WO2012150607A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104248627A (en) * 2013-06-25 2014-12-31 北大方正集团有限公司 Valproate semisodium-containing effervescent dry suspension and preparation method thereof
BE1026024B1 (en) * 2018-02-16 2019-09-16 Neogen Nv Method for preparing a solution comprising valproic acid and / or one or more of its salts, said solution and use
EP4017462A1 (en) 2019-12-16 2022-06-29 Colgate-Palmolive Company Oral care compositions containing inulin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009897A (en) 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
FR2643556B1 (en) 1989-02-27 1993-03-05 Sanofi Sa PHARMACEUTICAL COMPOSITION WITH SUSTAINED RELEASE OF VALPROIC ACID
US6511678B2 (en) 1998-12-18 2003-01-28 Abbott Laboratories Controlled release formulation of divalproex sodium
US6713086B2 (en) 1998-12-18 2004-03-30 Abbott Laboratories Controlled release formulation of divalproex sodium
US6528090B2 (en) 1998-12-18 2003-03-04 Abbott Laboratories Controlled release formulation of divalproex sodium
US6419953B1 (en) 1998-12-18 2002-07-16 Abbott Laboratories Controlled release formulation of divalproex sodium
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
US20110015267A1 (en) * 2009-07-20 2011-01-20 Deanna Jean Nelson Methods for the preparation and use of aqueous solutions of magnesium valproate hydrate and l-carnitine

Also Published As

Publication number Publication date
CL2013003137A1 (en) 2014-08-01
WO2012150607A3 (en) 2013-02-14
MX2013012827A (en) 2014-02-11
BR112013027685A2 (en) 2016-12-27
WO2012150607A2 (en) 2012-11-08
ECSP13013043A (en) 2014-01-31

Similar Documents

Publication Publication Date Title
BR112013018877A2 (en) pharmaceutical compositions comprising human antibodies to pcsk9
DK2694038T3 (en) PHARMACEUTICAL COMPOSITION
BR112013022112A2 (en) composition
DK3091029T3 (en) Anti-IL13 antibody formulations
BR112014003052A2 (en) pharmaceutical compositions
SMT201700110B (en) IMMUNOGENIC COMPOSITION
DK3192501T3 (en) TOPIC PHARMACEUTICAL COMPOSITION BASED ON SEMIFLURATED ALKANES
BR112013022102A2 (en) composition
DK2686017T3 (en) OFTALMIC COMPOSITION
BR112014004395A2 (en) composition
BR112013017183A2 (en) bepostatin compositions
BR112013031813A2 (en) composition for topical application
CO6930367A2 (en) Pharmaceutical compositions
CO6930368A2 (en) Stable iodine-povidone compositions
BR112013018875A2 (en) Methods and compositions for the preparation of noribogain from voacangin
BR112014006689A2 (en) oral care composition
BR112014009963A2 (en) dietary composition
BR112013033808A2 (en) composition
BR112014012519A2 (en) Method to Purify 1,3-Batadiene
CO6950486A2 (en) Solution for oral administration
BR112014009636A2 (en) Dietary composition to prevent cardiometabolic risk
DK2815752T3 (en) ORAL PHARMACEUTICAL COMPOSITION
CO7010828A2 (en) Pharmaceutical preparation comprising substituted ßcyclodextrin
CO6801753A2 (en) Compositions containing polyhydroxyoxuminium cations and manufacturing thereof
CU24163B1 (en) TYPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB

Legal Events

Date Code Title Description
FC Application refused